KRAS and pancreatic neoplasm: For example, CRC and pancreatic cancers have high Kras mutation rates, and our studies indicated that FL118 has high efficacy to treat CRC cell xenograft tumors [50] and pancreatic cancer patient-derived xenograft (PDX) tumors [69].